Click for best price
Prostate Cancer Screening Market Size, Share 2022
Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in those without signs or symptoms.
This report contains market size and forecasts of Prostate Cancer Screening in Global, including the following market information:
Global Prostate Cancer Screening Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Prostate Cancer Screening market was valued at 13820 million in 2021 and is projected to reach US$ 22650 million by 2028, at a CAGR of 7.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Physical Exam Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Screening include Abbott Laboratories, Almac, Bayer, Beckman Coulter, Biom?Rieux, Genomic Health, Mayo Clinic, Mdxhealth and Roche Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prostate Cancer Screening companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Screening Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Prostate Cancer Screening Market Segment Percentages, by Type, 2021 (%)
Physical Exam
Laboratory Tests
Imaging Tests
Gleason Score
TNM Score
Genetic Tests
Digital Rectal Exam
Biopsy
Global Prostate Cancer Screening Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Prostate Cancer Screening Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Research Labs
Cancer Institutes
Diagnostic Centers
Others
Global Prostate Cancer Screening Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Prostate Cancer Screening Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Screening revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Prostate Cancer Screening revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Almac
Bayer
Beckman Coulter
Biom?Rieux
Genomic Health
Mayo Clinic
Mdxhealth
Roche Diagnostics
Rosetta Genomics
Thermo Fisher Scientific
Hologic
Myriad Genetics
| Report Attributes |
Report Details |
| Report Title |
Prostate Cancer Screening Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Screening Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Screening Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Screening Overall Market Size
2.1 Global Prostate Cancer Screening Market Size: 2021 VS 2028
2.2 Global Prostate Cancer Screening Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Screening Players in Global Market
3.2 Top Global Prostate Cancer Screening Companies Ranked by Revenue
3.3 Global Prostate Cancer Screening Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Screening Companies in Global Market, by Revenue in 2021
3.5 Global Companies Prostate Cancer Screening Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Screening Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Screening Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Screening Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Prostate Cancer Screening Market Size Markets, 2021 & 2028
4.1.2 Physical Exam
4.1.3 Laboratory Tests
4.1.4 Imaging Tests
4.1.5 Gleason Score
4.1.6 TNM Score
4.1.7 Genetic Tests
4.1.8 Digital Rectal Exam
4.1.9 Biopsy
4.2 By Type - Global Prostate Cancer Screening Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Screening Revenue, 2017-2022
4.2.2 By Type - Global Prostate Cancer Screening Revenue, 2023-2028
4.2.3 By Type - Global Prostate Cancer Screening Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Screening Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Research Labs
5.1.5 Cancer Institutes
5.1.6 Diagnostic Centers
5.1.7 Others
5.2 By Application - Global Prostate Cancer Screening Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Screening Revenue, 2017-2022
5.2.2 By Application - Global Prostate Cancer Screening Revenue, 2023-2028
5.2.3 By Application - Global Prostate Cancer Screening Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Prostate Cancer Screening Market Size, 2021 & 2028
6.2 By Region - Global Prostate Cancer Screening Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Screening Revenue, 2017-2022
6.2.2 By Region - Global Prostate Cancer Screening Revenue, 2023-2028
6.2.3 By Region - Global Prostate Cancer Screening Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Prostate Cancer Screening Revenue, 2017-2028
6.3.2 US Prostate Cancer Screening Market Size, 2017-2028
6.3.3 Canada Prostate Cancer Screening Market Size, 2017-2028
6.3.4 Mexico Prostate Cancer Screening Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Screening Revenue, 2017-2028
6.4.2 Germany Prostate Cancer Screening Market Size, 2017-2028
6.4.3 France Prostate Cancer Screening Market Size, 2017-2028
6.4.4 U.K. Prostate Cancer Screening Market Size, 2017-2028
6.4.5 Italy Prostate Cancer Screening Market Size, 2017-2028
6.4.6 Russia Prostate Cancer Screening Market Size, 2017-2028
6.4.7 Nordic Countries Prostate Cancer Screening Market Size, 2017-2028
6.4.8 Benelux Prostate Cancer Screening Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Screening Revenue, 2017-2028
6.5.2 China Prostate Cancer Screening Market Size, 2017-2028
6.5.3 Japan Prostate Cancer Screening Market Size, 2017-2028
6.5.4 South Korea Prostate Cancer Screening Market Size, 2017-2028
6.5.5 Southeast Asia Prostate Cancer Screening Market Size, 2017-2028
6.5.6 India Prostate Cancer Screening Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Prostate Cancer Screening Revenue, 2017-2028
6.6.2 Brazil Prostate Cancer Screening Market Size, 2017-2028
6.6.3 Argentina Prostate Cancer Screening Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Screening Revenue, 2017-2028
6.7.2 Turkey Prostate Cancer Screening Market Size, 2017-2028
6.7.3 Israel Prostate Cancer Screening Market Size, 2017-2028
6.7.4 Saudi Arabia Prostate Cancer Screening Market Size, 2017-2028
6.7.5 UAE Prostate Cancer Screening Market Size, 2017-2028
7 Players Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Prostate Cancer Screening Major Product Offerings
7.1.4 Abbott Laboratories Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 Almac
7.2.1 Almac Corporate Summary
7.2.2 Almac Business Overview
7.2.3 Almac Prostate Cancer Screening Major Product Offerings
7.2.4 Almac Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.2.5 Almac Key News
7.3 Bayer
7.3.1 Bayer Corporate Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Prostate Cancer Screening Major Product Offerings
7.3.4 Bayer Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.3.5 Bayer Key News
7.4 Beckman Coulter
7.4.1 Beckman Coulter Corporate Summary
7.4.2 Beckman Coulter Business Overview
7.4.3 Beckman Coulter Prostate Cancer Screening Major Product Offerings
7.4.4 Beckman Coulter Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.4.5 Beckman Coulter Key News
7.5 Biom?Rieux
7.5.1 Biom?Rieux Corporate Summary
7.5.2 Biom?Rieux Business Overview
7.5.3 Biom?Rieux Prostate Cancer Screening Major Product Offerings
7.5.4 Biom?Rieux Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.5.5 Biom?Rieux Key News
7.6 Genomic Health
7.6.1 Genomic Health Corporate Summary
7.6.2 Genomic Health Business Overview
7.6.3 Genomic Health Prostate Cancer Screening Major Product Offerings
7.6.4 Genomic Health Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.6.5 Genomic Health Key News
7.7 Mayo Clinic
7.7.1 Mayo Clinic Corporate Summary
7.7.2 Mayo Clinic Business Overview
7.7.3 Mayo Clinic Prostate Cancer Screening Major Product Offerings
7.7.4 Mayo Clinic Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.7.5 Mayo Clinic Key News
7.8 Mdxhealth
7.8.1 Mdxhealth Corporate Summary
7.8.2 Mdxhealth Business Overview
7.8.3 Mdxhealth Prostate Cancer Screening Major Product Offerings
7.8.4 Mdxhealth Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.8.5 Mdxhealth Key News
7.9 Roche Diagnostics
7.9.1 Roche Diagnostics Corporate Summary
7.9.2 Roche Diagnostics Business Overview
7.9.3 Roche Diagnostics Prostate Cancer Screening Major Product Offerings
7.9.4 Roche Diagnostics Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.9.5 Roche Diagnostics Key News
7.10 Rosetta Genomics
7.10.1 Rosetta Genomics Corporate Summary
7.10.2 Rosetta Genomics Business Overview
7.10.3 Rosetta Genomics Prostate Cancer Screening Major Product Offerings
7.10.4 Rosetta Genomics Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.10.5 Rosetta Genomics Key News
7.11 Thermo Fisher Scientific
7.11.1 Thermo Fisher Scientific Corporate Summary
7.11.2 Thermo Fisher Scientific Business Overview
7.11.3 Thermo Fisher Scientific Prostate Cancer Screening Major Product Offerings
7.11.4 Thermo Fisher Scientific Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.11.5 Thermo Fisher Scientific Key News
7.12 Hologic
7.12.1 Hologic Corporate Summary
7.12.2 Hologic Business Overview
7.12.3 Hologic Prostate Cancer Screening Major Product Offerings
7.12.4 Hologic Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.12.5 Hologic Key News
7.13 Myriad Genetics
7.13.1 Myriad Genetics Corporate Summary
7.13.2 Myriad Genetics Business Overview
7.13.3 Myriad Genetics Prostate Cancer Screening Major Product Offerings
7.13.4 Myriad Genetics Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.13.5 Myriad Genetics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prostate Cancer Screening Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Screening Market Drivers in Global Market
Table 3. Prostate Cancer Screening Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Screening in Global Market
Table 5. Top Prostate Cancer Screening Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Prostate Cancer Screening Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Prostate Cancer Screening Revenue Share by Companies, 2017-2022
Table 8. Global Companies Prostate Cancer Screening Product Type
Table 9. List of Global Tier 1 Prostate Cancer Screening Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Screening Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Prostate Cancer Screening Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Prostate Cancer Screening Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Prostate Cancer Screening Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Prostate Cancer Screening Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Prostate Cancer Screening Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Prostate Cancer Screening Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Prostate Cancer Screening Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Prostate Cancer Screening Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Prostate Cancer Screening Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Prostate Cancer Screening Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Prostate Cancer Screening Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Prostate Cancer Screening Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Prostate Cancer Screening Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Prostate Cancer Screening Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Prostate Cancer Screening Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Prostate Cancer Screening Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Prostate Cancer Screening Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Prostate Cancer Screening Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Prostate Cancer Screening Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Prostate Cancer Screening Product Offerings
Table 32. Abbott Laboratories Prostate Cancer Screening Revenue (US$, Mn), (2017-2022)
Table 33. Almac Corporate Summary
Table 34. Almac Prostate Cancer Screening Product Offerings
Table 35. Almac Prostate Cancer Screening Revenue (US$, Mn), (2017-2022)
Table 36. Bayer Corporate Summary
Table 37. Bayer Prostate Cancer Screening Product Offerings
Table 38. Bayer Prostate Cancer Screening Revenue (US$, Mn), (2017-2022)
Table 39. Beckman Coulter Corporate Summary
Table 40. Beckman Coulter Prostate Cancer Screening Product Offerings
Table 41. Beckman Coulter Prostate Cancer Screening Revenue (US$, Mn), (2017-2022)
Table 42. Biom?Rieux Corporate Summary
Table 43. Biom?Rieux Prostate Cancer Screening Product Offerings
Table 44. Biom?Rieux Prostate Cancer Screening Revenue (US$, Mn), (2017-2022)
Table 45. Genomic Health Corporate Summary
Table 46. Genomic Health Prostate Cancer Screening Product Offerings
Table 47. Genomic Health Prostate Cancer Screening Revenue (US$, Mn), (2017-2022)
Table 48. Mayo Clinic Corporate Summary
Table 49. Mayo Clinic Prostate Cancer Screening Product Offerings
Table 50. Mayo Clinic Prostate Cancer Screening Revenue (US$, Mn), (2017-2022)
Table 51. Mdxhealth Corporate Summary
Table 52. Mdxhealth Prostate Cancer Screening Product Offerings
Table 53. Mdxhealth Prostate Cancer Screening Revenue (US$, Mn), (2017-2022)
Table 54. Roche Diagnostics Corporate Summary
Table 55. Roche Diagnostics Prostate Cancer Screening Product Offerings
Table 56. Roche Diagnostics Prostate Cancer Screening Revenue (US$, Mn), (2017-2022)
Table 57. Rosetta Genomics Corporate Summary
Table 58. Rosetta Genomics Prostate Cancer Screening Product Offerings
Table 59. Rosetta Genomics Prostate Cancer Screening Revenue (US$, Mn), (2017-2022)
Table 60. Thermo Fisher Scientific Corporate Summary
Table 61. Thermo Fisher Scientific Prostate Cancer Screening Product Offerings
Table 62. Thermo Fisher Scientific Prostate Cancer Screening Revenue (US$, Mn), (2017-2022)
Table 63. Hologic Corporate Summary
Table 64. Hologic Prostate Cancer Screening Product Offerings
Table 65. Hologic Prostate Cancer Screening Revenue (US$, Mn), (2017-2022)
Table 66. Myriad Genetics Corporate Summary
Table 67. Myriad Genetics Prostate Cancer Screening Product Offerings
Table 68. Myriad Genetics Prostate Cancer Screening Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Prostate Cancer Screening Segment by Type in 2021
Figure 2. Prostate Cancer Screening Segment by Application in 2021
Figure 3. Global Prostate Cancer Screening Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Screening Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Prostate Cancer Screening Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Screening Revenue in 2021
Figure 8. By Type - Global Prostate Cancer Screening Revenue Market Share, 2017-2028
Figure 9. By Application - Global Prostate Cancer Screening Revenue Market Share, 2017-2028
Figure 10. By Region - Global Prostate Cancer Screening Revenue Market Share, 2017-2028
Figure 11. By Country - North America Prostate Cancer Screening Revenue Market Share, 2017-2028
Figure 12. US Prostate Cancer Screening Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Prostate Cancer Screening Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Prostate Cancer Screening Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Prostate Cancer Screening Revenue Market Share, 2017-2028
Figure 16. Germany Prostate Cancer Screening Revenue, (US$, Mn), 2017-2028
Figure 17. France Prostate Cancer Screening Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Prostate Cancer Screening Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Prostate Cancer Screening Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Prostate Cancer Screening Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Prostate Cancer Screening Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Prostate Cancer Screening Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Prostate Cancer Screening Revenue Market Share, 2017-2028
Figure 24. China Prostate Cancer Screening Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Prostate Cancer Screening Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Prostate Cancer Screening Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Prostate Cancer Screening Revenue, (US$, Mn), 2017-2028
Figure 28. India Prostate Cancer Screening Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Prostate Cancer Screening Revenue Market Share, 2017-2028
Figure 30. Brazil Prostate Cancer Screening Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Prostate Cancer Screening Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Prostate Cancer Screening Revenue Market Share, 2017-2028
Figure 33. Turkey Prostate Cancer Screening Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Prostate Cancer Screening Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Prostate Cancer Screening Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Prostate Cancer Screening Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Almac Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bayer Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Beckman Coulter Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Biom?Rieux Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Genomic Health Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Mayo Clinic Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Mdxhealth Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Roche Diagnostics Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Rosetta Genomics Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Thermo Fisher Scientific Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Hologic Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Myriad Genetics Prostate Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
